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HIV dementia is a neurodegenerative disease for which
there is no available neuroprotective therapy. Viral pro-
teins, such as Tat, have been implicated as agents of neu-
rotoxicity via multiple mechanisms, including effects on
glutamate receptors.
We coincubated HIV-1 Tat protein with a monoclonal
antibody against the N-terminal of Tat, in human neuro-
nal cultures. The antibody significantly (P < 0.005) atten-
uated the neurotoxicity caused by Tat alone, as measured
by mitochondrial membrane potential. This protection
occurred despite previous observations that peptides from
the N-terminal of Tat are non-toxic. We hypothesized that
the antibodies may have a more indirect neuroprotective
function, preventing excitotoxicity at glutamate receptors.
Thus, we coincubated Tat and anti-Tat antibody with
NMDA and kainate, in our cultures. The Tat-antibody
combination attenuated the toxicity seen with NMDA (p
< 0.05). There was some protection against kainate
(AMPA) excitotoxicity, but it was not statistically signifi-
cant (p < 0.2).
The Tat-antiTat antibody complex appears to prevent exci-
totoxic effects at glutamate receptors, especially NMDA
receptors. Host immune responses may influence host
susceptibility to the effects of viral proteins, altering HIV
complications, such as onset of HIV dementia.
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